Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Rhythmlink, Graham Partners Form Investment Partnership - Medical Product Outsourcing
Financial & Business

Rhythmlink, Graham Partners Form Investment Partnership

The union will help ensure Rhythmlink's future growth.

Rhythmlink International LLC has forged a new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses.
 
Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues, according to company bigwigs. The investment was completed earlier this year.
 
“We’re excited about this next phase of Rhythmlink,” Rhythmlink Co-Founder/CEO Shawn Regan said. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities. I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us—improving patient care in our field of neurodiagnostics.”
 
This new relationship with Graham follows Rhythmlink’s successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under the partnership with New Heritage, Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded its existing product line to include EMG and NCV diagnostic consumable devices. 
 
“Our partnership with New Heritage was extremely beneficial,” Rhythmlink Chief Operating Officr/Chief Financial Officer Joe Straczek stated. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.”
 
Rhythmlink sells consumable neurodiagnostic devices for critical care, electroencephalography, intraoperative neuromonitoring, the emergency room and ICU, and long-term epilepsy monitoring. 

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters